Nutritional factors, especially phytoestrogens, have been extensively studied for their potential beneficial effects against hormone-dependent and age-related diseases. The present study describes the short-term effects of dietary phytoestrogens on regulatory behaviors (food/water intake, locomotor activity and body weight), prostate weight, prostate 5 -reductase enzyme activity, reproductive hormone levels, and testicular steroidogenic acute regulatory peptide (StAR) levels in adult Sprague-Dawley rats.
Introduction
Phytoestrogens (a group of natural selective estrogen receptor modulators) are non-steroidal, diphenolic structures found in many plants (e.g. fruits, vegetables, legumes, whole grain and especially soy products) that have the capacity to bind estrogen receptors ( and ) (Bradbury & White 1954 , Price & Fenwick 1985 , Setchell & Adlercreutz 1988 , Knight & Eden 1996 , Adlercreutz 1997 , Kuiper et al. 1997 , Setchell & Cassidy 1999 . These estrogen mimics have been shown in animal models and in limited clinical investigations to be protective in the prevention of: (1) hormone-dependent cancers (e.g. breast and prostate), (2) cardiovascular disease and (3) osteoporosis (Price & Fenwick 1985 , Setchell & Adlercreutz 1988 , Knight & Eden 1996 , Adlercreutz 1997 , Adlercreutz & Mazur 1997 , Setchell 1998 , Kumar & Besterman-Dahan 1999 , Setchell & Cassidy 1999 . The anti-cancer effects of phytoestrogens appear to be associated with several possible mechanisms, including their ability to inhibit tyrosine kinase(s), growth factors, DNA isotopoisomerase, steroidogenic enzymes and act as anti-oxidant and anti-angiogenic agents (Price & Fenwick 1985 , Setchell & Adlercreutz 1988 , Knight & Eden 1996 , Adlercreutz 1997 , Adlercreutz & Mazur 1997 , Griffiths et al. 1998 , Setchell 1998 , Setchell & Cassidy 1999 .
Epidemiological data have shown clear relationships between the incidence rates of prostate cancer (PCa) and soy food consumption. In Japan, the incidence of PCa is relatively low compared with that in the USA. Yet, despite the Japanese developing benign prostatic hyperplasia (BPH), rarely does it progress to a malignant cancer condition. This observation has led to the belief that phytoestrogen-rich diets may explain these observations (Adlercreutz 1997 , Adlercreutz & Mazur 1997 , Griffiths et al. 1998 , Kumar & Besterman-Dahan 1999 , Setchell & Cassidy 1999 . Support for this hypothesis comes from rodent studies where soy diets have been found to be protective against PCa cell growth (Makela et al. 1995a , Zhang et al. 1997 , Dalu et al. 1998 , Landstrom et al. 1998 , Bylund et al. 2000 , Choi et al. 2000 . Several human studies suggest that phytoestrogens inhibit BPH and PCa growth in vitro and in vivo (Stephens 1997 , Griffiths et al. 1998 , Stephens 1999 , Choi et al. 2000 . In the USA (and in other developed countries), PCa is the second most common cause of cancer death and BPH is a pre-malignant condition representing a major health concern in men. If a dietary approach to preventing either condition proves successful, this will have global implications. For this reason, we have attempted to determine whether high dietary phytoestrogen intake influences reproductive endocrine physiology in adult male rats in a manner that may be beneficial with regard to prevention of these diseases.
In this study, adult male Sprague-Dawley rats were fed either a high phytoestrogen diet or a phytoestrogen-free diet for approximately 5 weeks. Regulatory behaviors (food and water intake) and locomotor (open field) activity were measured along with recording body and prostate weight, prostate 5 -reductase enzyme activity, plasma testosterone, androstenedione, estradiol, luteinizing hormone (LH) and testicular steroidogenic acute regulatory protein (StAR) levels at the end of the study.
Materials and Methods

Animals
Adult male Sprague-Dawley (50-day-old) rats were obtained from Simonsen Laboratories (Gilroy, CA, USA) and were housed in a controlled environment on a reverse light-dark cycle (lights on 1600 to 0600 h; red light illumination during the dark cycle from 0600 to 1600 h). The animals were given free access to water and standard rat chow for approximately 20 days (days 50-70). The standard rat chow diet contains approximately 300 µg/g phytoestrogens.
Phytoestrogen diets
At 70 days of age, 114 rats were randomly assigned to two treatment groups: (1) a sterol-free diet (referred to hereafter as the Phyto-free diet) or (2) the phytoestrogen-rich containing diet (referred to hereafter as the Phyto-600 diet). There were no significant differences in body weight before the animals were assigned to the treatment groups and the animals continued to have free access to water and the diets. The Phyto-free rat diet was obtained from Zeigler Brothers (Gardner, PA, USA), balanced and matched for equivalent percentage content of protein, carbohydrate and fat to that of the commercially available Phyto-600 diet (Harlan-Teklad, Madison, WI, USA). The ingredients for each diet are compared in Table 1 . The concentration and type(s) of phytoestrogens in the two diets were analyzed in duplicate by reverse-phase high pressure liquid chromatography (HPLC) using a 25 0·46 cm Aquapore (C8; particle size 7 µm) column (Perkin Elmer, Bodman Industries, Aston, PA, USA) under gradient elution conditions, with internal controls, as described elsewhere (Coward et al. 1993 , Setchell et al. 1997 . The Phyto-600 diet contained approximately 600 µg/g phytoestrogens while the phytoestrogen content in the Phyto-free diet was below the limits of HPLC detection (see Table 2 ).
Food (g 0·1 g), water (m 0·5 ml) and body weight (g 0·1 g) measurements were recorded periodically throughout the study. Food intake was recorded by weighing each animal's food tray every 24 h during the treatment interval. Water intake was measured in ml from calibrated water bottles. After 35 days on the treatment diets (starting at 70 days of age), the male rats were killed at 105 days of age. At the time of death, trunk blood was collected, body weight was measured and ventral prostate weight determined (mg 0·5 mg). Plasma was prepared from the trunk blood and stored at −20 C until assayed. The animals and methods used in this study were approved by the Institutional Animal Care and Use Committee at Brigham Young University.
Plasma phytoestrogen levels
The concentration and type(s) of phytoestrogens were analyzed from two pooled (by treatment) plasma (in a subset of animals, total n=31 per treatment) samples by gas-chromatography/mass spectrometry. This was preformed by liquid-solid extraction and liquid-gel chromatographic techniques to isolate the phytoestrogen fractions using standard methods with stable isotopic labeled internal standards and control samples to validate the assay (Setchell et al. 1997) . Concentrations are expressed in ng/ml.
Locomotor activity
In a subset of animals (n=18 per group), before the diets were initiated, at 70 days of age and after the diets were administered, at 82 days of age (or 12 days on the diets) and at 99 days of age (or 29 days on the diets) the locomotor activity of the rats from each diet group was measured by open field tests (conducted at 1000-1200 h (during the dark cycle when rats are most active) under red light conditions, as previously described; Lephart et al. 1996 , Weber et al. 1999 
Radioimmunoassay -determination of plasma testosterone, androstenedione, estradiol and LH levels
In a subset of the treated animals (n=18 per group), plasma testosterone, androstenedione and estradiol levels were determined by radioimmunoassay (RIA) using kits from Diagnostic Systems Laboratories (Webster, TX, USA).
The estradiol values were obtained using an ultra-sensitive kit (RIA). All samples were run in a single assay (in duplicate by hormone tested) and the intra-assay coefficients of variation were 3% for testosterone, 4% for androstenedione and 7% for estradiol. LH levels were measured using reagents obtained from the National Hormone and Pituitary Program. The results obtained are expressed in terms of the LH-RP3 reference standards and the sensitivity of this assay was 0·07 ng/ml (Niswender et al. 1968) . The samples were run in a single assay in duplicate with an intra-assay coefficient of variation <7%.
Prostate 5 -reductase activity
To determine 5 -reductase activity in ventral prostate tissue (in a subset of animals, n=13 per group), the isolated tissue samples were incubated in 200 µl Dulbecco's 
Amino acids
The ingredients list (first four) for the Harlan-Teklad 8604 diet=soybean meal, corn and wheat flakes, ground corn and wheat middlings; for the Zeigler Brothers, sterol-free diet=corn, wheat, fish meal and wheat middlings (reproduced by permission of the suppliers). NA, not assayed. (Lephart et al. 1990) , the rates of 5 -reductase activity in each tissue sample were determined in the reaction mixture. In brief, at the end of the incubation period, the reaction was stopped and steroids in the reaction mixture were extracted with 5 vol. chloroform with subsequent vortexing. An aliquot of the chloroform phase (100 µl) was evaporated to dryness, re-dissolved in 30 µl chloroform containing 10 µg each of five non-radioactive steroids (5 -androstane-3 ,17-dione, androstenedione, 5 -dihydrotestosterone, testosterone and 5 -androstane-3 ,17 -diol). Each prepared sample was applied to precoated silica gel plastic thin layer chromatography (TLC) plates (20 20 cm). The TLC plates were developed with one ascent of the solvent system (dichloromethane, ethyl acetate, methanol; 85:15:3, by vol.), which resolves the major 5 -reduced metabolites from 5 -androgen metabolites, estradiol and estrone. The tritium corresponding to the cold 5 -reduced steroids was quantified by scintillation counting to calculate the 5 -reductase activities as corrected by blanks (reaction tubes containing no tissue) as standards (Lephart et al. 1990) . Using these conditions, the predominant enzyme activity measured was 5 -reductase type 1 (Normington & Russell 1992 ) which apparently is the major 5 -reductase type expressed in adult rat prostate tissue (Normington & Russell 1992) . The protein content of each tissue fragment assayed was determined by the method of Lowry et al. (1951) . The 5 -reductase activities were expressed as specific activity rate(s) in pmol/h (of incubation)/mg protein.
Testicular StAR protein Western analysis
The right testis of each Phyto-600 or Phyto-free animal (n=13 per diet group) was dissected and then stored at -85 C until assayed. The following procedure was performed in a cold room (4 C). The testicular tissues (by treatments) were thawed, cut into small sections and placed into 30 ml ice-cold TBS buffer, pH 7·0. The testicular tissues were dispersed by passing the tissue/ buffer mixture through an 18 gauge needle, then a 20 gauge needle five times each. The dispersed testicular tissue was then placed into a 50 ml conical tube for 5 min to allow the larger cell particles consisting of pieces of seminiferous tubules to settle to the bottom of the tube. Subsequently, 1 ml aliquots of the dispersed testicular tissue were collected for the upper portion of the conical tube, the protein content of each aliquot was determined by a Lowry protein assay (Lowry et al. 1951) and finally the samples were lyophilized. Lyophilized Leydig cell samples were analysed for expression of StAR by Western analysis as described previously (Clark et al. 1994) . The samples were solubilized in sample buffer (25 mM Tris/HCl, pH 6·8, 1% SDS, 5% -mercaptoethanol, 1 mM EDTA, 4% glycerol and 0·01% bromophenol blue), boiled for 5 min and loaded onto a 12% SDS-PAGE mini-gel (Mini-Protean II System; Bio-Rad, Richmond, CA, USA). Electrophoresis was performed at 200 V for 45 min using a standard SDS-PAGE running buffer (25 mM Tris, 192 mM glycine, 0·1% SDS, pH 8·3). The proteins were electrophoretically transferred to a polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA, USA) at 100 V for 2 h at 4 C using a transfer buffer containing 20 mM Tris, 150 mM glycine, 20% methanol, pH 8·3. The membrane was incubated in blocking buffer (PBS buffer containing 4% Carnation non-fat dry milk and 0·2% Tween 20), at room temperature for 1 h followed by incubation with a primary antibody against StAR for 30 min. Anti-StAR antisera against amino acids 88-98 of mouse StAR protein were produced in rabbits by Research Genetics (Huntsville, AL, USA). The membrane was washed with PBS containing 0·2% Tween 20 three times for 10 min each time. After incubation with the second antibody, donkey anti-rabbit IgG conjugated with horseradish peroxidase (Amersham, Arlington Heights, IL, USA), the membrane was washed five times for 10 min each time. Specific protein bands were detected by chemiluminescence using the Renaissance Kit (Dupont New England Nuclear, Wilmington, DE, USA), and quantitated using the BioImage Visage 2000 (Townson et al. 1996) .
Statistical analysis
The data derived from the adult male rats were tested by ANOVA, followed by pairwise comparisons (via Tukey's analysis) to detect significant differences between the treatment groups ( =P<0·05). For the open field data, repeated measures were used to detect significant differences between the treatment groups, followed by a post-hoc pairwise comparison via a Neuman-Kuels test ( =P<0·05).
Results
The total and individual isoflavones were determined in pooled plasma samples from animals in each diet group. The animals in the Phyto-600 group had significantly higher levels of phytoestrogens in their plasma compared with the Phyto-free treatment group (Fig. 1) . The total circulating concentration of plasma isoflavones was approximately 35 times higher in the Phyto-600 (2224 ng/ml) vs the Phyto-free (63 ng/ml) animals. Major components of the plasma phytoestrogen levels in the Phyto-600 animals were equol (]1000 ng/ml) and daidzein (]800 ng/ml) while genistein (]400 ng/ml) made up the remaining fraction of the circulating isoflavones. In the Phyto-free group, the phytoestrogens (equol, daidzein and genistein) were present in plasma but at very low concentrations compared with the Phyto-600 values (Fig. 1) .
For food intake, there were no significant differences between the Phyto-600 vs the Phyto-free fed animals near the end of the treatment interval (see Table 3 ). However, when water intake was examined, Phyto-600 fed animals displayed slight but significantly higher levels than Phytofree fed animals (Table 3) . Also, when body weight was measured at the end of the treatment period (compared to pre-treatment values), we observed a slight but significant decrease in body weight in the Phyto-600 (372·8 + 4·0 g) compared with the Phyto-free fed (391·6 + 3·4 g) animals (Table 3) .
Since there were no significant differences in food intake between the Phyto-600 vs the Phyto-free animals, open field tests were conducted to determine whether locomotor activity levels were altered by the diets (Fig. 2 ). There were no significant differences in open field activity before the animals were fed the Phyto-600 vs the Phytofree diets. However, after 12 days and at 29 days of feeding on the diets, the Phyto-600 group displayed higher open field locomotor levels compared with the Phyto-free group although the difference did not quite approach statistical significance (P<0·06) (Fig. 2) , suggesting a potential influence of dietary phytoestrogens on locomotor activity.
For animals fed the Phyto-600 diet, the prostate weight (alone or standardized by body weight) was significantly lower compared with the Phyto-free group (see Table 3 ). In order to gain an understanding of this result, prostate 5 -reductase activity was measured, since androgen hormonal action (via 5 -dihydrotestosterone) is known to act Figure 1 Plasma phytoestrogen concentrations from adult male rats fed the Phyto-600 or the Phyto-free diets for 5 weeks, expressed in ng/ml (means S.E.M.). Phytoestrogen concentrations were measured by gas chromatography/mass spectrometry (Setchell et al. 1997) . n=31, this represents the total of two independently pooled plasma samples assayed for each treatment. Total=sum of the three main phytoestrogen metabolites (equol, daidzein and genistein). Significantly higher plasma phytoestrogen levels in the Phyto-600 vs the Phyto-free animals is represented by the solid star. 157·6 3·7* Food and water intake represent the last 3 days of the diet treatment interval (averaged before the animals were killed at 120 days of age). Body and prostate weights were determined at the time of death. There were no significant differences in body weight by diet treatment group (at 70 days of age) before the treatment diets were administered (i.e. Phyto-600 group=304·3 2·7 g vs Phyto-free group=304·7 2·9 g). #Significantly greater water intake compared with Phyto-free values; *significantly greater values compared with Phyto-600 values.
as a trophic signal in this organ. There were no significant differences between the diet groups for prostate 5 -reductase activity (Phyto-600=113·0 3·0 pmol/h of incubation/mg protein vs Phyto-free=117·5 4·5 pmol/h of incubation/mg protein, n=13 per treatment group; data not shown graphically). Therefore, other hormonal signals were analyzed to potentially identify how a significant decrease in ventral prostate weight in the Phyto-600 group occurred. There was no significant difference in plasma LH values between the animals fed the two phytoestrogen diets (Table 4) ; however, a significant decrease in plasma testosterone concentrations was observed for animals fed the Phyto-600 vs the Phyto-free diets (Table 4 ). In fact, plasma testosterone levels were approximately 50% lower in animals fed the Phyto-600 compared with animals fed the Phyto-free diet.
To further determine the pattern of steroidogenesis in the Phyto-600 and Phyto-free animals, plasma androstenedione and estradiol levels were also measured by RIA (Table 4) . A significant decrease in plasma androstenedione levels was observed in the animals fed the Phyto-600 diet compared with the Phyto-free fed animals ( Table 4 ). The plasma androstenedione concentrations showed the same pattern as that of the plasma testosterone levels, being significantly lower in animals fed the Phyto-600 diet (Table 4) . However, in the case of androstenedione, there was a much greater reduction in the Phyto-600 animals vs the Phyto-free fed animals when compared with the testosterone results. Conversely, when plasma estradiol levels were determined, no significant differences were observed between the two groups of animals (Table 4) .
To examine whether the significant decrease in plasma testosterone observed in the Phyto-600 diet fed animals was related to changes in testicular StAR protein, levels of this protein were measured by Western analysis. There were no significant differences in testicular StAR protein levels between the two groups (data not shown). Figure 2 Open field activity of Phyto-600 vs Phyto-free fed male rats. The columns indicate the mean number of squares the rats, by treatment group, entered in a 3-min time-period (Lephart et al. 1996 , Weber et al. 1999 . Each bar represents the mean S.E.M. for open field activity and the number at the base of each bar indicates the total animals tested per treatment group. The open field activity levels for the Phyto-600 group at 12 and 29 days of treatment approached significance where the Phyto-600 group displayed higher locomotor activity levels than the Phyto-free group values (P<0·060, 12 days treatment; and P<0·065, 29 days treatment).
Table 4
Testosterone, LH, androstenedione and estradiol levels in male rats fed the Phyto-600 vs the Phyto-free diets. Values are means S.E.M. (n=18)
Phyto-600
Phyto-free
Testosterone (ng/ml) 1·3 0·2 2 ·6 0·3* LH (ng/ml) 0·40 0·05 0·37 0·08 Androstenedione (ng/ml) 0·015 0·001 0·097 0·014* Estradiol (pg/ml) 4·2 0·42 4·5 0·80
Finally, when testicular characteristics were examined, there were no significant differences in testes weight, Sertoli or Leydig cell number or morphology between the Phyto-600 vs the Phyto-free fed animals (data not shown).
Discussion
Interest in the health effects of phytoestrogens has increased dramatically during the past years where agerelated and hormone-dependent diseases appear to be influenced by the consumption of these plant estrogen-like molecules (Setchell & Adlercreutz 1988 , Knight & Eden 1996 , Adlercreutz 1997 , Adlercreutz & Mazur 1997 , Murkies et al. 1998 , Setchell 1998 , Kumar & BestermanDahan 1999 , Setchell & Cassidy 1999 . The present study attempts to understand the possible mechanisms of action of phytoestrogens as they relate to PCa prevention by examining hormonal, reproductive and behavioral responses in an animal model fed a phytoestrogen-rich diet.
The content of the phytoestrogen diet utilized in this study was similar to that previously used. The total isoflavone concentration was approximately 600 µg/g phytoestrogens (designated as the Phyto-600 diet), while the Phyto-free diet had no detectable isoflavones by HPLC with UV detection (Lephart et al. 2000) . The circulating plasma phytoestrogen concentration of animals fed the Phyto-600 diet (]2200 ng/ml) is similar to that in people eating a typical Asian diet (of approximately 1 µM). Animals fed the Phyto-free diet had very low plasma phyotestrogens levels (]70 ng/ml) reflecting what is observed in humans consuming a typical Western diet. By this approach, we are effectively establishing a dietary model for comparing Asian with Western diets for the consumption of phytoestrogens.
Estrogens are known to alter feeding behavior, bodyweight composition and significantly increase locomotor behavior in rats (Gray et al. 1979 , Mooradian et al. 1987 . In this study, animals fed the Phyto-600 diet displayed a slight but significant decrease in body weight after 5 weeks on this diet compared with animals fed the Phyto-free diet and this is consistent with the estrogenic hormonal action of these molecules (Mooradian et al. 1987 , Anderson et al. 1988 . Furthermore, since phytoestrogens have been shown to transfer into brain tissue (Lephart et al. 2000) and have similar physiochemical and physiological characteristics to endogenous estrogens (Setchell & Adlercreutz 1988 , Knight & Eden 1996 , Adlercreutz 1997 , Murkies et al. 1998 , Setchell 1998 , Setchell & Cassidy 1999 , locomotor behavior tests revealed that Phyto-600 fed animals showed slight (but nonsignificant; P<0·06) increases in open field behavior compared with the animals fed a Phyto-free diet. This significant decrease in body weight observed in these animals fed the Phyto-600 diet suggests that the Phyto-600 diet may increase locomotor activity. (In another study, we have data to support the notion that Phyto-600 fed animals display significantly increased locomotor activity; however, we have also obtained preliminary data where significant differences in absorption/ metabolism may account for the differences in body weight where alterations in leptin and adipose tissue deposition are seen between Phyto-600 and Phyto-free fed animals.)
Long-term dietary studies where animals have been exposed to phytoestrogens show influences on prostate and other markers of reproductive development (Sharma et al. 1992 , Makela et al. 1995a , Zhang et al. 1997 . When reproductive organs were examined, Phyto-600 fed animals displayed a significant reduction in ventral prostate weight compared with Phyto-free fed animals. The mechanism for this change is unknown but may relate to changes in steroid hormone status within the prostate itself by effects on the levels of enzymes regulating steroid hormone production. It is known that phytoestrogens can inhibit prostate 5 -reductase enzyme activity in vitro (Evans et al. 1995) , but our studies did not find significant alterations in prostate 5 -reductase enzyme activity after feeding the Phyto-600 diet that could account for the changes in prostate weight.
However, the Phyto-600 fed animals had significantly lower plasma androgen levels when compared with the Phyto-free fed animals. This reduction in testosterone could account for the reduced prostate weight in these animals, because the ventral prostate is androgen sensitive. In previous (longer term) studies, changes in androgen levels were not noted (Sharma et al. 1992 , Makela et al. 1995a , Zhang et al. 1997 ; however, circulating phytoestrogen levels were not measured in these studies and, therefore, such differences are difficult to reconcile. Additionally, we have previously observed a similar pattern of circulating testosterone reduction in animals on the Phyto-600 diet (at approximately 40-50% of Phytofree values) in three independent studies under the same experimental conditions, representing an n of 39 rats per treatment group. Another possible explanation for this finding is that phytoestrogens have the ability to inhibit the aromatase enzyme in peripheral tissues (Kellis & Vickery 1984 , Ibrahim & Abul-Hajj 1990 , Wang et al. 1994 ) and the apparent protection phytoestrogens have against BPH and PCa may be via the reduction in local estrogen formation since estrogenic agents are known to be mitogenic (vom Saal et al. 1997 , Griffiths et al. 1998 , Farnsworth 1999 , Shibata et al. 2000 , Yaono et al. 2000 .
On the other hand, the inter-conversion of testosterone to androstenedione is regulated by the activity of 17 -hydroxysteroid dehydrogenase, an enzyme that has been shown to be influenced by phytoestrogens (Makela et al. 1995b) . Changes in plasma androstenedione levels with the Phyto-600 diet were much lower compared with those observed for testosterone by dietary treatments, suggesting that the substrate supply or enzyme regulation for testosterone synthesis may be affected by the phytoestrogen-rich diet. No changes in plasma LH or estradiol levels were observed between the Phyto-600 animals and the Phyto-free fed animals that could account for the changes in the observed testosterone levels. Finally, in an attempt to determine whether phytoestrogens may alter cholesterol delivery into the steroidogenic pathway, we measured StAR activity but found no significant differences in testicular StAR levels between the Phyto-600 and the Phyto-free groups. However, it is possible that the 30 kDa StAR protein analyzed in these experiments may not represent newly synthesized StAR and thus the protein measured would not be active in cholesterol transfer (Townson et al. 1996) . It is also possible that the effects of phytoestrogens may be manifested at the level of protein kinase activity in the prostate. It is known that genistein decreases tyrosine phosphorylation in endocrine tissue (Fioravanti et al. 1998) . Finally, the decrease in testosterone levels in the Phyto-600 animals remains to be explained but represents a consistent observation (Sharma et al. 1992 , Landstrom et al. 1998 . It is possible that phytoestrogens affect the biosynthetic pathways for androgen production by an unknown mechanism.
The reduction in prostate weight in the Phyto-600 fed animals is in agreement with findings by other investigators. Soy-containing diets were shown to inhibit prostatitis and prostate adenocarcinoma in rodents and to reduce prostate size in humans with BPH (Sharma et al. 1992 , Stephens 1997 , Griffiths et al. 1998 , Landstrom et al. 1998 , Bylund et al. 2000 . However, in the above rodent studies, prostatic parameters were reduced without changes in testosterone levels among the treatment groups (Sharma et al. 1992 , Landstrom et al. 1998 . Thus, the mechanisms across species and presumably among rat strains may represent diverse and complex processes by which phytoestrogens protect against certain types of hormone-dependent cancers and BPH (vom Saal et al. 1997 , Griffiths et al. 1998 , Farnsworth 1999 , Negri-Cesi et al. 1999 , Shibata et al. 2000 , Yaono et al. 2000 .
In summary, the findings of this study highlight the biological actions of phytoestrogens on male reproductive endocrinology and may explain, in part, the protective effect of these estrogen mimics in male reproductive disorders such as BPH and PCa.
